To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC5159 | Tiracizine Hydrochloride |
Anti-arrhythmia agent
More description
|
|
| DCC5158 | tipp-703 |
hPPAR-pan agonist
More description
|
|
| DCC5157 | tipp-401 |
Dual PPA
More description
|
|
| DCC5156 | tipp-204 |
hPPAR
More description
|
|
| DCC5155 | Tioxolone |
Novel hepcidin antagonist
More description
|
|
| DCC5154 | Tinyatoxin |
Neurotoxin, acting via vanilloid receptors of sensory nerves
More description
|
|
| DCC5153 | Tinostamustine Hydrochloride |
Novel pan-histone-deacetylase inhibitor with alkylating activity
More description
|
|
| DCC5152 | Tilorone Dihydrochloride |
Antiviral, antineoplastic, and anti-inflammatory agent; Orally active interferon inducer, inhibiting Ebola virus (EBOV)
More description
|
|
| DCC5151 | Tilmicosin Phosphate |
Macrolide antibiotic for the treatment of bovine respiratory disease and ovine respiratory disease associated with Mannheimia (Pasteurella) haemolytica
More description
|
|
| DCC5150 | Tillman Reagent |
Widely used oxidation-reduction indicator
More description
|
|
| DCC5149 | Tigilanol Tiglate |
Natural anticancer agent fortreatment of mast cell tumor (MCT)
More description
|
|
| DCC5148 | Tiemonium Iodide |
Muscarinic receptor antagonist, anticholinergic,and parasympatholytic
More description
|
|
| DCC5147 | Tiancimycin |
Anthraquinone-fused enediyne antitumor agent for development of antibody-drug conjugates (ADCs)
More description
|
|
| DCC5146 | Tiagabine |
Anti-epileptic and anticonvulsant agent, acting as a selective GABA reuptake inhibitor
More description
|
|
| DCC5145 | Thrx160209 |
Novel multivalent ligand that bridges the allosteric and orthosteric binding sites of the M2 muscarinic receptor
More description
|
|
| DCC5144 | Thrombin-in-3g |
Novel selective thrombin inhibitor, inducing conformational allostery
More description
|
|
| DCC5143 | Thr101 |
Novel dose-dependent inhibitor of HDAC1, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, and HDAC9; NOX Inhibitor
More description
|
|
| DCC5142 | Thpp-4 |
Phosphodiesterase 10A (PDE10A) inhibitor
More description
|
|
| DCC5141 | Thpp-2 |
Novel phosphodiesterase 10A (PDE10A) inhibitor for treatment of schizophrenia
More description
|
|
| DCC5140 | Thpp-11f |
Novel potent, highly selective and orally available PI3Kδ inhibitor
More description
|
|
| DCC5139 | Th-pf03 |
Novel orthosteric-allosteric dual inhibitor of PfHT1 as selective antimalarial agent
More description
|
|
| DCC5138 | Th-pf02 |
Novel orthosteric-allosteric dual inhibitor of PfHT1 as selective antimalarial agent
More description
|
|
| DCC5137 | Th-pf01 |
Novel orthosteric-allosteric dual inhibitor of PfHT1 as selective antimalarial agent
More description
|
|
| DCC5136 | Thk-523 |
Selective Tau ligand, selectively binding to neurofibrillary tangles and neuropils in people with Alzheimer's disease
More description
|
|
| DCC5135 | Thiq-20c |
Steroidomimetic and Chimeric Microtubule Disruptor
More description
|
|
| DCC5134 | Thioxodihydroquinazolinone-19 |
Novel inducer of apoptotic cell death in platinum-resistant A2780cis human ovarian cancer cells, exhibitong a strong inhibitory effect in ovarian CSC-LCs in combination with cisplatin
More description
|
|
| DCC5133 | Thiowurtzine |
Novel Potent Inhibitor of the Opioid Receptors and the Ion Channels
More description
|
|
| DCC5132 | Thiomuscimol Hydrobromide |
GABAA receptor agonist
More description
|
|
| DCC5131 | Thioluciferin |
Firefly luciferin analog as a key element of bioluminescent reporters for oxidation state and thiol/disulfide equilibria
More description
|
|
| DCC5130 | Thioguanine-18 |
Novel potent DENV2-NS2B/NS3pro inhibitor
More description
|
|
